Diltiazem infusion for renal protection in cardiac surgical patients with preexisting renal dysfunction

被引:26
作者
Bergman, ASF [1 ]
Odar-Cederlöf, I
Westman, L
Bjellerup, P
Höglund, P
Öhqvist, G
机构
[1] Karolinska Hosp & Inst, Dept Anaesthesiol & Intens Care, SE-17176 Stockholm, Sweden
[2] Karolinska Hosp & Inst, Dept Clin Chem, SE-17176 Stockholm, Sweden
[3] Karolinska Hosp & Inst, Dept Med, Div Nephrol, SE-17176 Stockholm, Sweden
[4] Univ Lund Hosp, Clin Pharmacol Sect, S-22185 Lund, Sweden
[5] Karolinska Hosp & Inst, Dept Cardiothorac Anaesthet & Intens Care, SE-17176 Stockholm, Sweden
关键词
anesthesia; calcium antagonists; cardiac surgery; diltiazem; kidney function; postoperative complications;
D O I
10.1053/jcan.2002.124136
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective: To evaluate if the calcium channel blocker diltiazem protects postoperatively renal function in cardiac surgical patients with preexisting mild-to-moderate renal dysfunction. Design: Prospective, randomized, placebo-controlled, double-blind, clinical study. Setting: Cardiothoracic anesthesia department at a university hospital. Participants: Adult patients undergoing elective cardiac surgery using cardiopulmonary bypass, with a preoperatively elevated serum creatinine level (n = 24). Interventions: Randomized infusions of diltiazem (bolus 0.25 mg/kg followed by a continuous infusion of 1.7 pg/kg/min) (DTZ, n = 12) or placebo (C, n = 12) were started 30 minutes before induction of anesthesia and continued for 24 hours. Measurements and Main Results: Median plasma concentrations of diltiazem (DTZ group) were 79 mug/L before cardiopulmonary bypass, 67 mug/L at the end of cardiopulmonary bypass, and 164 mug/L at 24 hours postoperatively. Serum creatinine levels; on postoperative days 1, 3, and 5; and 3 weeks postoperatively were similar between groups. lohexol clearance did not differ between the groups on day 5 but was higher in the DTZ group than in the placebo group 3 weeks after surgery (median, 51 v 40 mL/min/1.73 m(2); p < 0.05). Urinary N-acetyl-β-glucosamidase concentrations were similar between the groups during the study but were increased from baseline on days 2 and 4 and 3 weeks postoperatively. Conclusion: Diltiazem can be safely used in patients who have mild-to-moderate renal dysfunction and undergo cardiac surgery using cardiopulmonary bypass. Within the limits of this study, the data suggest that addition of prophylactic diltiazem may prevent further glomerular damage resulting from cardiopulmonary bypass and may improve glomerular function 3 weeks after cardiac surgery. Copyright 2002, Elsevier Science (USA). All rights reserved.
引用
收藏
页码:294 / 299
页数:6
相关论文
共 37 条
  • [1] EFFECT OF CALCIUM-ANTAGONIST DILTIAZEM ON RENAL-FUNCTION IN OPEN-HEART-SURGERY
    AMANO, J
    SUZUKI, A
    SUNAMORI, M
    TOFUKUJI, M
    [J]. CHEST, 1995, 107 (05) : 1260 - 1265
  • [2] BEAL SL, 1982, CRIT REV BIOMED ENG, V8, P195
  • [3] RENAL AND HEMODYNAMIC-EFFECTS OF DILTIAZEM AFTER ELECTIVE MAJOR VASCULAR-SURGERY - A POTENTIAL RENOPROTECTIVE AGENT
    BERGMAN, ASF
    ODARCEDERLOF, I
    WESTMAN, L
    [J]. RENAL FAILURE, 1995, 17 (02) : 155 - 163
  • [4] Systemic effects of normothermic cardiopulmonary bypass
    Bert, AA
    [J]. ARTIFICIAL ORGANS, 1998, 22 (01) : 77 - 81
  • [5] Effects on renal function of a continuous infusion of nifedipine during cardiopulmonary bypass
    Bertolissi, M
    Antonucci, F
    DeMonte, A
    Padovani, R
    Giordano, F
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 1996, 10 (02) : 238 - 242
  • [6] CHAN L, 1990, ANNU REV MED, V41, P289
  • [7] Chertow GM, 1997, CIRCULATION, V95, P878
  • [8] Colson P, 1992, J Cardiothorac Vasc Anesth, V6, P424, DOI 10.1016/1053-0770(92)90007-T
  • [9] EPSTEIN M, 1992, KIDNEY INT, V41, pS66
  • [10] EPSTEIN M, 1992, ARCH INTERN MED, V152, P1573